Oruka Therapeutics (NASDAQ:ORKA) Hits New 1-Year Low – Here’s What Happened
Oruka Therapeutics, Inc. (NASDAQ:ORKA – Get Free Report) shares reached a new 52-week low during trading on Monday . The ...
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Average Rating of “Buy” from Brokerages
Shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA – Get Free Report) have been given a consensus recommendation of “Buy” by the ...
Yahoo Finance2d
Oruka Therapeutics, Inc. (ORKA)
After hours: December 31 at 7:15:09 PM EST Loading Chart for ORKA ...
Business Insider2d
Percheron Therapeutics Director Boosts Shareholding
Percheron Therapeutics (AU:PER) has released an update. Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with ...
Business Insider3d
Avalo Therapeutics (AVTX) Has a New Rating from BTIG
BTIG analyst Julian Harrison initiated coverage with a Buy rating on Avalo Therapeutics (AVTX – Research Report) today and set a price target of $40.00. The company’s shares closed today at $7.80.
Yahoo Finance6d
Coeptis Therapeutics Announces Reverse Stock Split
The first day of trading on a post-split basis on the Nasdaq Capital Market, will be at market open on December 31, 2024. Upon the effective date of the Reverse Split, every 20 shares of the ...
Forbes6d
C4 Therapeutics
C4 Therapeutics, Inc. engages in the development of targeted protein degradation science to develop a new generation of small molecule medicines used for treating diseases. It develops the ...
Investing1d
Kyverna Therapeutics Inc (KYTX)
Kyverna Therapeutics, Inc. (KYTX), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune ...